Dimitri Daldegan‐Bueno

680 citations
34 papers · 359 indexed · h-index 12
Topics
Psychedelics and Drug Studies (18 papers)Cannabis and Cannabinoid Research (17 papers)Substance Abuse Treatment and Outcomes (10 papers)
Journals
SHILAP Revista de lepidopterologíaNeuroscience & Biobehavioral ReviewsPsychopharmacology
Partner nations
BrazilNew ZealandCanada

In The Last Decade

Dimitri Daldegan‐Bueno

33 papers receiving 350 citations

Peers

Dimitri Daldegan‐Bueno
Comparison fields: 5 of 79
  • Clinical Psychology 185
  • Pharmacology 139
  • Cellular and Molecular Neuroscience 67
  • Epidemiology 65
  • Nutrition and Dietetics 64
Replace Evelyn Doering-Silveira with:
Evelyn Doering-Silveira Brazil
Maha N. Mian United States
Rhys Ponton New Zealand
Kevin H. Yang United States
Ofir Livne United States
Udo Schneider Germany
Joel Sales Giglio Brazil
Timothy I. Michaels United States
Kyle T. Greenway Canada
Natalie Gukasyan United States
Dimitri Daldegan‐Bueno relative to Evelyn Doering-Silveira Brazil Evelyn Doering-Silveira's profile →
Citations per field
00.5×7.9×
Evelyn Doering-Silveira · 1×
Citations per year

Countries citing papers authored by Dimitri Daldegan‐Bueno

Since Specialization
Citations

This map shows the geographic impact of Dimitri Daldegan‐Bueno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitri Daldegan‐Bueno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitri Daldegan‐Bueno more than expected).

Fields of papers citing papers by Dimitri Daldegan‐Bueno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimitri Daldegan‐Bueno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitri Daldegan‐Bueno. The network helps show where Dimitri Daldegan‐Bueno may publish in the future.

Co-authorship network of co-authors of Dimitri Daldegan‐Bueno

This figure shows the co-authorship network connecting the top 25 collaborators of Dimitri Daldegan‐Bueno. A scholar is included among the top collaborators of Dimitri Daldegan‐Bueno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimitri Daldegan‐Bueno. Dimitri Daldegan‐Bueno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 0
4 9
5 3
6 3
7 3
8 9
9 45
10 25
11 16
12 1
13 40
14 23
15 10
16 8
17 13
18 2
19 4
20 16

About Dimitri Daldegan‐Bueno

Dimitri Daldegan‐Bueno is a scholar working on Toxicology, Pharmacology and Clinical Psychology, having authored 34 papers that have together received 359 indexed citations. Recurring topics across this work include Psychedelics and Drug Studies (18 papers), Cannabis and Cannabinoid Research (17 papers) and Substance Abuse Treatment and Outcomes (10 papers). The work is most often cited by research in Clinical Psychology (185 citations), Pharmacology (139 citations) and Toxicology (20 citations). Dimitri Daldegan‐Bueno has collaborated with scholars based in Brazil, New Zealand and Canada. Frequent co-authors include Benedikt Fischer, Lucas Oliveira Maia, Luís Fernando Tófoli, Maria Gabriela Menezes Oliveira, Altay Alves Lino de Souza, Didier Jutras‐Aswad, Dráulio Barros de Araújo, Joseph M. Boden, Peter Reuter and Tessa Robinson. Their work appears in journals such as SHILAP Revista de lepidopterología, Neuroscience & Biobehavioral Reviews and Psychopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026